Concern about the use of venlafaxine to treat vasomotor symptoms--reply

Affiliations

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts3Massachusetts General Hospital, Harvard Medical School, Boston.
² MsFLASH Data Coordinating Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington5Department of Family and Preventative Medicine, University of California, San Diego.
³ Massachusetts General Hospital, Harvard Medical School, Boston.

Comment

Hadine Joffe et al. JAMA Intern Med. 2015 Apr.

. 2015 Apr;175(4):658-9.

doi: 10.1001/jamainternmed.2014.7997.

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts3Massachusetts General Hospital, Harvard Medical School, Boston.
² MsFLASH Data Coordinating Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington5Department of Family and Preventative Medicine, University of California, San Diego.
³ Massachusetts General Hospital, Harvard Medical School, Boston.

No abstract available

Comment on

Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC, Hunt J, Shifren J, Rexrode KM, Caan B, Sternfeld B, Carpenter JS, Cohen L. Joffe H, et al. JAMA Intern Med. 2014 Jul;174(7):1058-66. doi: 10.1001/jamainternmed.2014.1891. JAMA Intern Med. 2014. PMID: 24861828 Free PMC article. Clinical Trial.
Concern about the use of venlafaxine to treat vasomotor symptoms.
Zhou SS, Lun YZ, Li D. Zhou SS, et al. JAMA Intern Med. 2015 Apr;175(4):657-8. doi: 10.1001/jamainternmed.2014.7988. JAMA Intern Med. 2015. PMID: 25844750 No abstract available.